175 related articles for article (PubMed ID: 3890960)
1. Cytochemical localization of adenylate cyclase in the dense tubule system of human blood platelets stimulated by forskolin, prostacyclin and prostaglandin D2.
Cutler LS; Christian CP; Feinstein MB
Biochim Biophys Acta; 1985 Jun; 845(3):403-10. PubMed ID: 3890960
[TBL] [Abstract][Full Text] [Related]
2. Cytochemical localization of K(+)-dependent p-nitrophenyl phosphatase and adenylate cyclase by using one-step method in human washed platelets.
González-Utor AL; Sánchez-Aguayo I; Hidalgo J
Histochemistry; 1992 Jul; 97(6):503-7. PubMed ID: 1330994
[TBL] [Abstract][Full Text] [Related]
3. Cytochemical localization of adenylate cyclase and of calcium ion, magnesium ion-activated ATPases in the dense tubular system of human blood platelets.
Cutler L; Rodan G; Feinstein MB
Biochim Biophys Acta; 1978 Sep; 542(3):357-71. PubMed ID: 150866
[TBL] [Abstract][Full Text] [Related]
4. Reversal of thrombin-induced myosin phosphorylation and the assembly of cytoskeletal structures in platelets by the adenylate cyclase stimulants prostaglandin D2 and forskolin.
Feinstein MB; Egan JJ; Opas EE
J Biol Chem; 1983 Jan; 258(2):1260-7. PubMed ID: 6571835
[TBL] [Abstract][Full Text] [Related]
5. Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.
Zavoico GB; Feinstein MB
Biochem Biophys Res Commun; 1984 Apr; 120(2):579-85. PubMed ID: 6329175
[TBL] [Abstract][Full Text] [Related]
6. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
Feinstein MB; Egan JJ; Sha'afi RI; White J
Biochem Biophys Res Commun; 1983 Jun; 113(2):598-604. PubMed ID: 6307295
[TBL] [Abstract][Full Text] [Related]
7. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets.
Dutta-Roy AK; Ray TK; Sinha AK
Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935
[TBL] [Abstract][Full Text] [Related]
8. Desensitization of prostaglandin-activated platelet adenylate cyclase.
Cooper B; Schafer AI; Puchalsky D; Handin RI
Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
[TBL] [Abstract][Full Text] [Related]
9. Diminished platelet adenylate cyclase activation by prostaglandin D2 in acute thrombosis.
Cooper B
Blood; 1979 Sep; 54(3):684-93. PubMed ID: 380688
[TBL] [Abstract][Full Text] [Related]
10. The local anaesthetic benzyl alcohol attenuates the alpha 2-adrenoceptor-mediated inhibition of human platelet adenylate cyclase activity when stimulated by prostaglandin E1, but not that stimulated by forskolin.
Spence S; Houslay MD
Biochem J; 1989 Dec; 264(2):483-8. PubMed ID: 2557841
[TBL] [Abstract][Full Text] [Related]
11. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
12. Forskolin sensitizes human platelet adenylate cyclase to modulation of substrate (MgATP) affinity by hormones.
Watanabe Y; Jakobs KH
Biochem J; 1986 Jul; 237(1):273-6. PubMed ID: 3492195
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]forskolin to human platelet membranes. Regulation by guanyl-5'-yl imidodiphosphate, NaF, and prostaglandins E1 and D2.
Nelson CA; Seamon KB
J Biol Chem; 1986 Oct; 261(29):13469-73. PubMed ID: 3463564
[TBL] [Abstract][Full Text] [Related]
14. Human platelet adenylate cyclase: persistent binding of guanine nucleotide is central to the regulation of both hormone-stimulated and basal activities.
Olson CV; Smiley PA; Lad PM
Biochim Biophys Acta; 1985 Jun; 845(3):411-20. PubMed ID: 3924118
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of prostaglandin D2 receptors on human platelets by analogs of prostacyclin.
Alvarez R; Eglen RM; Chang LF; Bruno JJ; Artis DR; Kluge AF; Whiting RL
Prostaglandins; 1991 Aug; 42(2):105-19. PubMed ID: 1775633
[TBL] [Abstract][Full Text] [Related]
16. Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.
Jakobs KH; Bauer S; Watanabe Y
Eur J Biochem; 1985 Sep; 151(2):425-30. PubMed ID: 4040856
[TBL] [Abstract][Full Text] [Related]
17. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
18. Effects of PGI2 on platelet aggregation and adenylate cyclase activity in human type IIa hypercholesterolemia.
Colli S; Lombroso M; Maderna P; Tremoli E; Nicosia S
Biochem Pharmacol; 1983 Jul; 32(13):1989-93. PubMed ID: 6347202
[TBL] [Abstract][Full Text] [Related]
19. Desensitization of prostacyclin responsiveness in platelets. Apparent differences in the mechanism in vitro or in vivo.
MacDermot J
Biochem Pharmacol; 1986 Aug; 35(16):2645-9. PubMed ID: 2427086
[No Abstract] [Full Text] [Related]
20. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
Bonne C; Martin B; Watada M; Regnault F
Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
